Literature DB >> 8906614

Protease nexin I (PNI) in mouse brain is expressed from the same gene as in seminal vesicle.

B A Citron1, K T Ratzlaff, I V Smirnova, B W Festoff.   

Abstract

Protease nexin I (PNI), a serine protease inhibitor (serpin), is the most potent tissue inhibitor of thrombin. In the nervous system, PNI has been shown to participate in processes related to synaptic plasticity and neuronal survival. We assigned the human gene for PNI (P17) to chromosome 2q33-35, and to syntenic regions in mouse chromosome 1. Others showed that a similar serpin was expressed in mouse seminal vesicle, which presented the possibility of a "duplicate" gene. The data also raised controversy over the quantity of PNI mRNA expressed in the brain vs peripheral tissues, such as seminal vesicle. In order to further our investigations of PNI regulation and its influence on neuronal survival and neuroprotection, it was necessary to confirm whether the nexin observed in mouse brain samples was identical to the published protease nexin I sequences. To accomplish this, we performed DNA sequence analysis of cDNAs made from RNAs isolated from mouse forebrain and hindbrain as well as from seminal vesicle. These confirmed the identity of the mouse PNI gene (SPI4) in brain and peripheral tissues. Furthermore, Northern hybridization studies indicated that the PNI message is present at lower levels in the adult brain compared to the adult seminal vesicle. Western immunoblotting showed no differences between brain and seminal vesicle PNI proteins. The PNI cDNAs generated will serve as useful probes for the continued characterization of the serpin:protease balance as it relates to nerve cell function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906614     DOI: 10.1007/BF02736839

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  Plasminogen activators and inhibitors in the neuromuscular system: III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses.

Authors:  B W Festoff; J S Rao; D Hantaï
Journal:  J Cell Physiol       Date:  1991-04       Impact factor: 6.384

Review 2.  The agrin hypothesis.

Authors:  U J McMahan
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1990

Review 3.  Building synapses: agrin and dystroglycan stick together.

Authors:  J R Fallon; Z W Hall
Journal:  Trends Neurosci       Date:  1994-11       Impact factor: 13.837

4.  A molecular mechanism for synapse elimination: novel inhibition of locally generated thrombin delays synapse loss in neonatal mouse muscle.

Authors:  M N Zoubine; J Y Ma; I V Smirnova; B A Citron; B W Festoff
Journal:  Dev Biol       Date:  1996-11-01       Impact factor: 3.582

5.  Neuronal expression of protease-nexin 1 mRNA in rat brain.

Authors:  C S Simpson; H M Johnston; B J Morris
Journal:  Neurosci Lett       Date:  1994-04-11       Impact factor: 3.046

6.  A synaptic localization domain in the synaptic cleft protein laminin beta 2 (s-laminin)

Authors:  P T Martin; A J Ettinger; J R Sanes
Journal:  Science       Date:  1995-07-21       Impact factor: 47.728

7.  Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells.

Authors:  J B Baker; D A Low; R L Simmer; D D Cunningham
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

8.  A serine protease inhibitor, protease nexin I, rescues motoneurons from naturally occurring and axotomy-induced cell death.

Authors:  L J Houenou; P L Turner; L Li; R W Oppenheim; B W Festoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

9.  The glia-derived protease nexin 1 persists for over 1 year in rat brain areas selectively lesioned by transient global ischaemia.

Authors:  C Nitsch; A L Scotti; D Monard; C Heim; K H Sontag
Journal:  Eur J Neurosci       Date:  1993-03-01       Impact factor: 3.386

10.  A glia-derived neurite-promoting factor with protease inhibitory activity.

Authors:  J Guenther; H Nick; D Monard
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

View more
  1 in total

Review 1.  The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies.

Authors:  Barry W Festoff; Chris Dockendorff
Journal:  Biomolecules       Date:  2021-10-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.